CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL
Product details
Registration number: SIN15075P
Classification: Prescription Only
Active ingredients: Ceftazidime Pentahydrate eqv Ceftazidime
Strength: 2000mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
ATC code: J01DD02
HSA approval date: 25 August 2016
Manufacturer(s):
- Labesfal – Laboratorios Almiro, S.A.
- Hanmi Fine Chemical Co. Ltd (Sterile Anhydrous Sodium Carbonate)
- Hanmi Fine Chemical Co. Ltd (Sterile Ceftazidime buffered with sodium carbonate)
Manufacturing country/countries: KOREA, REPUBLIC OF; PORTUGAL
What are the HSA registration number and classification for CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15075P
Classification: Prescription Only
What active ingredients and strength are recorded for CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ceftazidime Pentahydrate eqv Ceftazidime
Strength: 2000mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Labesfal – Laboratorios Almiro, S.A.
- Hanmi Fine Chemical Co. Ltd (Sterile Anhydrous Sodium Carbonate)
- Hanmi Fine Chemical Co. Ltd (Sterile Ceftazidime buffered with sodium carbonate)
Manufacturing country/countries: KOREA, REPUBLIC OF; PORTUGAL
Where can I look up CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15075P or the exact product name CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL. The general register link does not preselect this product.
What are the source dates for this CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CEFTAZIDIME KABI POWDER FOR SOLUTION FOR INJECTION 2G/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15075P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)